Clinical Trial Update: Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (≥15 mm) Classified Bethesda III or IV on Cytology [Phase 2, Phase 3]

View source ↗

Summary

A completed phase 2/3 trial evaluating the combination of ultrasonography with Ti-RADS scoring and dual tracer scintigraphy (MIBI Tc-99m and Iodine-123) for det…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: Nantes University Hospital | Conditions: Malignancy of Thyroid Nodules | Phase 2, Phase 3 | Status: COMPLETED